Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

 

 

 

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra's Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck

This content is available to members only.

If you are an existing member, please LOGIN

Note a member? Sign up for a FREE trial account ($195 per month value), and get immediate access. Free offer expires June 15, 2019.

Register New Account

Free Membership

.

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2
subscribe@wallstreetreporter.com.




Related Articles

CEO Interview

MassRoots, Inc. (OTC: MSRT) Offering turnkey solutions for cannabis industry

February 26, 2019 admin CEO Interview, Consumer Comments Off on MassRoots, Inc. (OTC: MSRT) Offering turnkey solutions for cannabis industry

              MassRoots, Inc. (OTC: MSRT) Interview with CEO, Isaac Dietrich discussing the company’s services to the cannabis industry. Discussion includes: MassRoots app and WeedPass market progress, and the COWA […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Investor Presentations

Vitality Biopharma (OTC: VBIO) Cannabinoids to Treat Serious Neurological and Inflammatory Conditions

July 13, 2018 admin Investor Presentations Comments Off on Vitality Biopharma (OTC: VBIO) Cannabinoids to Treat Serious Neurological and Inflammatory Conditions

Cannabinoids to Treat Serious Neurological and Inflammatory Conditions Add to my social media sitesSubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati